‘Cytotron’, a medical invention by Bengaluru based scientist Rajah Vijay Kumar to help in cancer treatment has got the honour of being called a ‘breakthrough device’ in cancer care by the USA’s Food and Drug Administration’s (FDA) Centre for Device and Radiological Health
‘Cytotron’ aids in tissue engineering of cancer cells, altering how specific proteins are regulated to stop these cells from multiplying and spreading, reported Times of India.
The device was developed at the Centre for Advanced Research and Development in Bhopal, and is meant to cause the degeneration of uncontrolled growth of tissues.
How it Works
Cytotron uses fast radio bursts (FRB), high energy and powerful short radio bursts in which both electric and magnetic components of the electromagnetic signals are "circularly" polarised.
As it was developed in India and hardly any parts need to be imported, the device is set to be produced in India itself.
The Centre for Device and Radiological Health is responsible for the premarket approval of the medical device in the USA.
Cytotron has already been approved and in use in various countries including UAE, Mexico, Malaysia, Hong Kong among others.
(With inputs from Times of India)
(Delhi is in a public health emergency. The air outside is visibly toxic - how has the hazardous air #pollution impacted you? Write down your #PollutionKaSolution and send it to us at FIT@thequint.com. )
(This story was auto-published from a syndicated feed. No part of the story has been edited by The Quint.)
(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)
We'll get through this! Meanwhile, here's all you need to know about the Coronavirus outbreak to keep yourself safe, informed, and updated.
Liked this story? We'll send you more. Subscribe to The Quint's newsletter and get selected stories delivered to your inbox every day. Click to get started.
The Quint is available on Telegram & WhatsApp too, click to join.